Updated:
Shin Kong Venture Capital
Shin Kong Venture Capital invests in the greater China region, evaluating targets through industry research and company visits. The firm leverages resources...
Shin Kong Venture Capital
Shin Kong Venture Capital invests in the greater China region, evaluating targets through industry research and company visits. The firm leverages resources from SKFH and its subsidiaries for support. As of available data, Shin Kong Venture Capital has made three investments, including a Series A - II investment in UMBO CV on October 08, 2019.
General information
Firm type
Venture Capital
Year founded
2011
Location
Region
Asia
Country
Taiwan
City
Taipei
Corporate office
Taipei, Taiwan
Additional offices
Philadelphia · Palo Alto
Sector focus
Frequently asked questions
Who makes investment decisions at Shin Kong Venture Capital?
Shin Kong Venture Capital does not publicly disclose its investment committee or principals. The firm operates as a corporate venture capital arm of Shin Kong Group, so decisions likely involve senior management from the group's insurance and financial holdings divisions (per the firm's corporate structure).
Does Shin Kong Venture Capital invest as a limited partner in funds or only via direct deals?
The firm participates in both fund commitments and direct co-investments. Public records show the firm has made direct investments in companies like Insilico Medicine (per public record), suggesting a dual strategy of fund investments and direct equity stakes alongside US venture partners.
What investment stages does Shin Kong Venture Capital target?
Shin Kong Venture Capital focuses on early- to growth-stage companies. Its portfolio includes both venture-stage and later-stage private companies in technology and healthcare (per public record).
Which sectors does Shin Kong Venture Capital explicitly avoid?
The firm does not publicly disclose any sector restrictions. Based on its known portfolio, it appears to avoid energy, real estate, and consumer-facing businesses, focusing instead on enterprise software, AI/ML, and healthcare.
How is Shin Kong Venture Capital related to Shin Kong Group?
Shin Kong Venture Capital is the corporate venture capital arm of Shin Kong Group, a Taiwanese conglomerate whose primary businesses include life insurance (Shin Kong Life), banking (Shin Kong Bank), and financial holdings. The venture unit invests capital from the group's balance sheet, not external LP commitments (per public record and corporate structure).
Where does the underlying wealth for Shin Kong Venture Capital come from?
The capital originates from Shin Kong Group's insurance premiums, banking deposits, and retained earnings from its financial services operations. The group is publicly listed on the Taiwan Stock Exchange and is controlled by the Wu family (per public record).
Does Shin Kong Venture Capital maintain any philanthropic or non-investment activities?
Shin Kong Group operates a separate corporate social responsibility program, the Shin Kong Life Cultural & Educational Foundation, which focuses on arts, education, and elderly care in Taiwan. The venture capital arm does not directly manage these activities (per the group's official communications).
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: